SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-20-001809
Filing Date
2020-03-26
Accepted
2020-03-26 16:09:30
Documents
100
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2241053z10-k.htm 10-K 1490918
2 EX-4.3 a2241053zex-4_3.htm EX-4.3 8659
3 EX-10.13 a2241053zex-10_13.htm EX-10.13 47438
4 EX-21.1 a2241053zex-21_1.htm EX-21.1 4463
5 EX-23.1 a2241053zex-23_1.htm EX-23.1 2836
6 EX-31.1 a2241053zex-31_1.htm EX-31.1 8892
7 EX-31.2 a2241053zex-31_2.htm EX-31.2 8884
8 EX-32 a2241053zex-32.htm EX-32 8204
15 G837867.JPG g837867.jpg GRAPHIC 41264
  Complete submission text file 0001047469-20-001809.txt   8045650

Data Files

Seq Description Document Type Size
9 EX-101.INS cldx-20191231.xml EX-101.INS 1840051
10 EX-101.SCH cldx-20191231.xsd EX-101.SCH 58573
11 EX-101.CAL cldx-20191231_cal.xml EX-101.CAL 75659
12 EX-101.LAB cldx-20191231_lab.xml EX-101.LAB 581918
13 EX-101.PRE cldx-20191231_pre.xml EX-101.PRE 460818
14 EX-101.DEF cldx-20191231_def.xml EX-101.DEF 233801
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 20746239
SIC: 2835 In Vitro & In Vivo Diagnostic Substances